Telomerase antibody and nuclear and senescence reagents that are scarce or transient

Getting nuclear stains and blots to work

1. Extract the nucleus rather than the cell. Chromatin and envelope associated proteins stay in the pellet with a standard buffer. A nuclear extraction, with the pellet checked, is what puts them on a blot.
2. Prefer activity where abundance is very low. For enzymes present at a handful of copies per cell, an activity assay is more sensitive and more meaningful than an attempt to detect the protein directly.
3. Name the isoform for envelope proteins. Splice isoforms of nuclear envelope proteins differ in tissue distribution and in disease relevance, and reagents differ in which they see. The datasheet has to state it.
4. Treat RNA binding proteins as mobile. These proteins relocalise into granules and between compartments on stress. A change in staining pattern is frequently relocalisation rather than expression, and fractionation or imaging is what distinguishes them.
5. Denature before detecting incorporated nucleotide. An antibody against an incorporated base cannot reach it in double stranded DNA. Acid or enzymatic denaturation is a required step, and it damages other epitopes in the same sample.

Compartment before reagent

For this group, where the protein is matters more than which antibody is used. A reagent that works beautifully on a nuclear extract will show nothing in a cytoplasmic lysate, and the reverse is equally true.

Fractionate once with validated markers and the question of where each target lives in your cells is settled for good.

Relocalisation looks like regulation

Proteins that move between compartments produce apparent changes in expression when only one compartment is examined. That is a systematic error rather than noise, and it points in a consistent direction.

Where a target is known to move, image it or fractionate. A whole cell blot cannot see the event that matters.

A glutathione antibody and the adduct it reports

Glutathione itself is a small molecule, so an antibody against it is raised on a conjugate and what is usually being measured is protein glutathionylation rather than free glutathione. A glutathione antibody therefore reports an adduct on proteins, and the free pool is measured enzymatically or by chromatography instead. Sample handling decides the result, since the adducts are reduced easily.

A sirt1 antibody and a deacetylase read by substrate

SIRT1 abundance changes little, so a sirt1 antibody is used for expression and knockdown validation while activity is read as the acetylation of a named substrate. It shuttles between compartments, so a fractionation carries information a whole lysate does not. Reported effects of activators have been contested, which is why the substrate readout rather than the enzyme level is the honest measurement.

A yy1 antibody and a factor present everywhere

YY1 is ubiquitous and binds many promoters, so a yy1 antibody is used for occupancy at a specific site, for a pulldown or as a nuclear reference rather than to show a presence. For chromatin work the clone needs validation in that application specifically. The protein is modified in several ways, so more than one band is expected and the datasheet should name them.

A tbp antibody and the loading reference it provides

TATA binding protein is stable and nuclear, which is why a tbp antibody is a standard loading reference for nuclear extracts in the way that a cytoskeletal protein serves whole lysates. Using it as a reference and as a subject at the same time is the error to avoid. It is part of a large complex, so an immunoprecipitation brings the other subunits with it.

A brd9 antibody and a chromatin complex subunit

BRD9 defines the non canonical form of a chromatin remodelling complex, so a brd9 antibody is how that complex is identified, and its degradation by a selective degrader is the functional tool the field uses. It is chromatin associated, so the fraction and a histone loading reference decide whether a faint band is real, and the bromodomain family's relatives are the cross reactivity to rule out.

A cnot1 antibody and the scaffold of a deadenylase complex

CNOT1 is the large scaffold of the CCR4-NOT complex, so a cnot1 antibody is used to pull the complex down and to confirm a knockdown that the rest of a figure rests on. Its size makes transfer the usual failure. Because the complex degrades messenger RNA, the readout of interest is transcript stability rather than the scaffold's own level.

A bach1 antibody and a repressor degraded by haem

BACH1 represses antioxidant genes until haem binds it and triggers its degradation, so a bach1 antibody reports a level that falls in exactly the condition the pathway is being tested in, and that fall is the result rather than a failed blot. A proteasome inhibitor lane holds it up. Its target genes are the readout that makes a repression claim.

Common questions

Why can I not detect telomerase?

Because it is present at extremely low copy number in most cells. Activity assays are the standard approach, and a detection attempt without enrichment is likely to fail whatever the reagent.

Does a stress granule marker measure stress?

It measures granule formation, which is one response to some stresses. Total protein does not change, so the measurement is the number and size of granules per cell, which is an imaging readout.

Why does BrdU antibodies detection need denaturation?

The epitope is inside double stranded DNA and inaccessible. Denaturation exposes it and damages protein epitopes at the same time, which is why co-staining needs a compatible protocol or a different label chemistry.

Browse by service class

• Compare Gene synthesis on advertised prices